Today: 21 June 2026
Destiny Tech100 Stock Surges Again As DXYZ’s SpaceX And AI Bet Draws Fresh Traders

Destiny Tech100 Stock Surges Again As DXYZ’s SpaceX And AI Bet Draws Fresh Traders

New York, May 4, 2026, 14:04 EDT

Destiny Tech100 Inc. surged 13.4% Monday afternoon, grabbing attention on the NYSE as traders snapped up shares for a shot at private-tech holdings like SpaceX, OpenAI, and Databricks. Shares were last seen changing hands at $39.36, off a high of $39.82, with more than 3.66 million shares already traded.

This is notable: Destiny Tech100 operates as a closed-end fund, so its shares aren’t tied directly to portfolio value and can swing well above or below that mark. According to the most recent audit, the fund’s NAV as of Dec. 31 was $19.93 per share. Monday’s closing price? Nearly double that figure—about 97% higher than the reported value.

The trade boils down to that gap. Buyers aren’t only picking up the last disclosed portfolio—they’re also after access, scarcity, and the possibility those private AI and space bets get marked up ahead of when regular investors have a shot at them.

SpaceX sits at the top of Destiny Tech100’s portfolio, making up 16.2% of its economic exposure. Shield AI follows at 4.1%, with Databricks close behind at 4.0%. OpenEvidence and xAI are tied at 3.5% each. As of Dec. 31, nearly half—47.3%—of the unaudited portfolio sits in cash equivalents. That gives the fund firepower, but also throws the premium into sharper relief.

Back in February, the fund disclosed it had wrapped up three more deals post-year-end, putting roughly $127 million toward Anthropic, CHAOS Industries, and Hermeus. “Destiny Tech100 was created to unlock access to the world’s most ambitious private companies,” CEO Sohail Prasad said then. Business Wire

The filing supplement also noted Destiny Tech100’s at-the-market stock sale program, capped at $1 billion. In the fourth quarter, the fund moved 8,121,853 shares, pulling in net proceeds of roughly $244.6 million. These types of programs allow closed-end funds to pull in fresh capital when shares are hot, but they bring share count and per-share metrics into sharper focus for investors.

Destiny Tech100 has some company now in the public market’s hunt for private tech. Robinhood’s RVI fund started trading in March, featuring names like Databricks, Ramp, and Revolut. Fundrise’s VCX, meanwhile, is aimed at private tech plays spanning AI, machine learning, data infrastructure, and software.

The danger: premiums can vanish before portfolios catch up. “Trading at a massive premium and then seeing the premium quickly collapse is not unique to Fundrise Innovation, as we saw the same pattern occur with Destiny Tech100,” Jack Shannon, equity strategies principal at Morningstar Inc., told Bloomberg in March. Mark Klein, CEO of Suro Capital, emphasized that investors need to know exactly what’s in the fund, how those assets are valued, and if the market price still lines up with those numbers. mint

Destiny Tech100’s prospectus doesn’t mince words: expect volatility in both share price and trading volume. Closed-end funds like this often see their stock trade below net asset value. Risks stack up with venture-backed holdings—think scant public data, brief track records, and no guarantees that portfolio firms deliver the exits investors are hoping for.

DXYZ isn’t acting much like a traditional fund lately—it’s moving more in sync with whatever mood is driving private AI and space bets. That cuts both ways. A hot day in the sector and the premium jumps, but if valuations get knocked back or trading turns soft, the stock could quickly slide back to its underlying portfolio value.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Top 3 FTSE Shares for Beginner Investors to Buy in 2026
    June 21, 2026, 3:05 AM EDT. AstraZeneca, RELX, and another leading FTSE stock stand out as strong picks for beginner investors in 2026. AstraZeneca, a global pharmaceutical giant, boasts a 'best in class' drug pipeline with a raised price target of 16,500p by Bank of America, highlighting potential sales growth despite risks from clinical trial outcomes. RELX, an information analytics provider embedding AI into its platforms, is seen as a 'mis-priced AI beneficiary' with shares trading below historical multiples after a tough 2025. These companies offer durable moats and growth prospects, but investors should weigh optimisms against inherent risks like clinical failures and AI adoption speed.

Latest articles

Home Depot shares finish week up as investors weigh housing numbers

Home Depot shares finish week up as investors weigh housing numbers

21 June 2026
Home Depot jumped 2.1% to $334.28 in a shortened week as Wall Street rallied, but weak U.S. housing starts and upcoming May new-home-sales data keep pressure on the home-improvement outlook; the company reaffirmed 2026 sales and earnings targets despite volatile conditions and persistent housing affordability concerns.
Blaize Stock Jumps as $15 Million Winmate AI Deal Targets Defense Hardware
Previous Story

Blaize Stock Jumps as $15 Million Winmate AI Deal Targets Defense Hardware

Sivers Semiconductors Stock Jumps 47% as Nasdaq Push and AI Optics Bet Hit Deadline Week
Next Story

Sivers Semiconductors Stock Jumps 47% as Nasdaq Push and AI Optics Bet Hit Deadline Week

Go toTop